Tell us more about your current role and Altamira Therapeutics.
I am director of Technical Development / CMC at Altamira Therapeutics, which is a company which is dedicated to developing therapeutics in the field of otorhinolaryngology and recently expanded also into RNA based therapeutics. One of our major projects is a nasal spray, AM-125, which is currently in phase 2 development for the treatment of vertigo.
KYBORA is inspired by a word from Rwanda that means “guide”; this is where our CEO Alan Vanderborght was born and raised. Our mission is to help and support the growth of our Life Sciences clients by focusing on transactions as well as on strategic consulting services. Our specialty is in M&A (on the buy-side as well as on the sell-side), licensing (in and out) and fundraising.
Cube Labs is an industrial holding in Life Sciences. We act in three dimensions: the first is tech transfer from the Italian Academia, thanks to a strategic partnership with the largest Italian Consortium, I.N.B.B. (www.inbb.it made of 24 public universities), where we serve as a technology platform.
I truly love chemistry. I enjoy creating compounds that no one has designed before. It is amazing, how with a small set of atoms and a limited set of chemistry rules, I have infinite possibilities to create new structures that interact with biological systems. Just like a painter who can impress on canvas, an endless number of ideas and emotions with a few colors.
